Scott Kinlay MBBS, PhD

Adjunct Associate Professor, Cardiovascular Medicine

Associate Professor, Medicine

72 E. Concord Street
Scott Kinlay
Sections

Cardiovascular Medicine

Biography

Dr. Scott Kinlay is the Chief of Cardiology and Director of Vascular Medicine at the VA Boston Healthcare System, West Roxbury Campus. He is affiliated with Brigham and Women's Hospital. He is currently licensed to practice medicine in Massachusetts.

Other Positions

Education

Medicine-Surgery, MBBS, University of Sydney

Epidemiology, PhD, University of Newcastle

Publications

Published on 4/30/2026

Kinlay S, Kinlay JR. Network Meta-Analysis of Two Methods of Stent Optimisation Using Intravascular Imaging During Percutaneous Coronary Interventions. Heart Lung Circ. 2026 Apr 30. PMID: 42067453.

Published on 4/22/2026

Peloso GM, Adhikari N, Young MM, Cho K, Kinlay S. Genome-Wide Association Study of Chronic Venous Insufficiency and Lymphedema in the Million Veteran Program. Circ Genom Precis Med. 2026 Apr 22; e005442. PMID: 42017216.

Published on 3/23/2026

Yuyun MF, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Gaziano JM, Orkaby AR. Management of Arrhythmias in Older Adult Patients =75 Years Old Compared to Younger Patients <75 Years Old: Is Contemporary Practice Reflective of Evidence? Cardiol Rev. 2026 Mar 23. PMID: 41870966.

Published on 2/24/2026

Kinlay S, Farber A, Menard MT, Strong MB, Dake MD, Kaufman J, Schneider PA, Conte MS, Shaw PM, Kashyap VS, Rosenfield K, Doros G, Siracuse JJ, Powell RJ. Major Adverse Limb Events and Death After Successful Endovascular Revascularization: BEST-CLI Trial. J Soc Cardiovasc Angiogr Interv. 2026 Mar; 5(3):104192. PMID: 41868765.

Published on 1/12/2026

Hicks CW, Farber A, Doros G, Kinlay S, Powell RJ, Strong MB, Rosenfield K, Aridi H, Motaganahalli R, Barleben A, Siracuse JJ, Azene E, Malas M, Conte MS, Zayed M, Menard MT. Atherectomy Is Not Associated With Improved Limb-Based Outcomes Among Patients in the BEST-CLI Trial Undergoing Endovascular Revascularization. JACC Cardiovasc Interv. 2026 Jan 12; 19(1):96-107. PMID: 41534992.

Published on 12/5/2025

Ohiomoba R, Mandieka E, Young MM, Gagnon DR, Kinlay S. Relationship of cancer and dual antiplatelet duration to long-term risk of ischaemic and bleeding outcomes after percutaneous coronary intervention. Eur Heart J Open. 2026 Jan; 6(1):oeaf163. PMID: 41560900.

Published on 9/22/2025

Neisius U, Kinlay S. Microvascular and Macrovascular Disease: The S'mores of Peripheral Artery Disease. Circ Cardiovasc Interv. 2025 Oct; 18(10):e015961. PMID: 40977390.

Published on 4/22/2025

Kashyap VS, Beckman JA, Doros G, Menard MT, Rosenfield K, Creager MA, Tuttle KR, McGinigle KL, Huber T, Kinlay S, Drooz AT, Strong MB, Weinberg I, Farber A, Jaff MR. Optimal Medical Therapy Is Associated With Improved Limb Outcomes in PAD Patients: A BEST-CLI Substudy. J Am Coll Cardiol. 2025 Apr 22; 85(15):1568-1572. PMID: 40240095.

Published on 4/7/2025

Gornik HL, Aronow HD, Goodney PP, Arya S, Packard Brewster L, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Antonio Gutiérrez J, Hawkins BM, Hess CN, Ho KJ, Schuyler Jones W, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, West Pollak A, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR. Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Apr 08; 151(14):e918. PMID: 40193537.

Published on 4/1/2025

Kinlay S. Revascularization for Chronic Limb-Threatening Ischemia-Synthesizing Inconsistency. J Soc Cardiovasc Angiogr Interv. 2025 May; 4(5):102623. PMID: 40454267.

View full list of 183 publications.